-
Cariprazine, sold
under the
brand name
Vraylar among others, is an
atypical antipsychotic developed by
Gedeon Richter,
which is used in the treatment...
- brexpiprazole,
cariprazine, olanzapine, and
quetiapine have been
approved as
adjunct treatment for MDD by the FDA in the
United States.
Cariprazine, Quetiapine...
- Richter's
atypical antipsychotic, Reagila,
containing the
active ingredient cariprazine, was
awarded the
prize of
Medicine of the Year 2019 by the Hungarian...
- (+sertraline)
Aripiprazole lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724...
-
Atypical antipsychotics (e.g., aripiprazole, asenapine, brexpiprazole,
cariprazine, clozapine, lurasidone, quetiapine, ziprasidone)
Azapirones (e.g., buspirone...
-
antidepressant efficacy in
bipolar disorder (with the
notable exceptions being cariprazine, quetiapine,
olanzapine and
possibly asenapine) as a monotherapy, even...
-
Atypical antipsychotics (e.g., aripiprazole, asenapine, brexpiprazole,
cariprazine, clozapine, lurasidone, quetiapine, ziprasidone)
Azapirones (e.g., buspirone...
- (+sertraline)
Aripiprazole lauroxil Bifeprunox Brexpiprazole Brilaroxazine Cariprazine F-15063
Lumateperone Norclozapine Others: 3-PPP A-412997 ABT-670 ABT-724...
- stabilizers. Some
atypical antipsychotics (aripiprazole, asenapine,
cariprazine, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone)...
- for
brexpiprazole vs 4.1% for placebo, and 9.2% for
cariprazine vs 4.7% for placebo.
Cariprazine had a 3%
weight gain over
placebo on its
highest dose...
